Rakovina Therapeutics (TSXV:RKV) FFO


TSXV:RKV Rakovina Therapeutics Inc TSXV:RKV
32 GF Score
Price C$0.13
! 1 Warning Sign
View Full Analysis

What is Rakovina Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

TSXV:RKV
32GF Score
Rakovina Therapeutics Inc TSXV:RKV
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rakovina Therapeutics Business Description

Other Exchanges RKVTF:USA7JO0:Germany
Address 999 West Broadway, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.
32GF Score

Get the complete analysis for TSXV:RKV

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.13
Price